Comprehensive ubiquitome analysis reveals persistent mitochondrial remodeling disruptions from doxorubicin-induced cardiotoxicity in aged CD-1 male mice

  • 0Associate Laboratory i4HB - Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313, Porto, Portugal. sofiarbrandao@ua.pt.

|

|

Summary

This summary is machine-generated.

Doxorubicin (DOX) causes lasting heart damage in aged mice, impairing mitochondrial function and increasing protein ubiquitination. These molecular changes persist for months after treatment, highlighting the need for extended patient monitoring.

Area Of Science

  • Biochemistry
  • Cardiology
  • Molecular Biology

Background

  • Doxorubicin (DOX) cardiotoxicity has long-term effects, with mechanisms poorly understood.
  • Aging exacerbates DOX-induced heart damage.

Purpose Of The Study

  • To investigate the enduring cardiac molecular impacts of DOX in aged mice.
  • Focus on ubiquitinated proteins and mitochondrial function.

Main Methods

  • Aged male CD-1 mice received DOX or saline.
  • Cardiac tissue analyzed 2 months post-administration.
  • Assessed protein ubiquitination, E3 ligase levels, mitochondrial markers, and autophagy-related proteins.

Main Results

  • DOX induced cardiac structural changes and increased proteolytic activity.
  • Elevated protein ubiquitination observed, despite decreased Atrogin-1.
  • Increased poly-ubiquitination of sarcomere and mitochondrial proteins.
  • Enhanced mitochondrial density and citrate synthase activity.
  • Reduced mitochondrial biogenesis and autophagy markers (PGC-1α, Beclin1, LC3).

Conclusions

  • DOX causes persistent mitochondrial dysfunction and accumulation of damaged mitochondria in aged hearts.
  • Impaired protein ubiquitination and disrupted mitochondrial remodeling are lasting consequences of DOX treatment.
  • Findings support extended clinical surveillance for DOX-treated patients due to enduring cardiotoxicity.